Puget Technologies

Fort Lauderdale, Florida
Logo for Puget Technologies
Is this your profile?

Claim it and begin making changes yourself.

Claim It

About this Organization

Puget Technologies (OTCQB: PUGE) is a publicly traded company focused on investing in companies that stay ahead of the curve and offer innovative products. Cannabis Biotech, a wholly owned subsidiary of Puget Technologies, is forging new frontiers in cannabinoid research and distribution. As the world grows to accept cannabis-based medicines, we are poised to meet the demand. Its other subsidiary, B-29, is responsible for manufacturing naturally-infused energy drinks.

Associates

Ron Leyland
President & CEO
Ron Leyland serves as President and CEO of Puget Technologies, the publicly-traded parent company of Cannabis Biotech. He is responsible for guiding the company’s overall direction, implementing their mission and vision. Further, Leyland is in charge of developing strategic opportunities to increase share-holder value. Before his time with Puget Technology, Leyland founded Nexagen USA in 2002. Leveraging the company’s successful launch of its initial proprietary product, the Jen Fe Diet Patch, he assembled an expert research and development team. They went on to develop a well-accepted product line consisting of patches, pills, lotions and drinks utilizing multiple delivery systems. Leyland …

Similar Companies

Logo for Plandai Biotechnology
Plandai Biotechnology
Seattle, Washington
Based in Seattle, Plandai Biotechnology is a publicly-traded company that delivers highly bioavailable, phytonutrient rich extracts under the trademark, Phytofare™. In early 2014, Plandai submitted a request for ministerial dispensation to the Secretary of Parliament of South Africa, asking for the allowance of cannabis research. The company hopes to develop cannabis extract medicines for the treatment of cancer.
Logo for Nuvilex, Inc.
Nuvilex, Inc.
Silver Spring, Maryland
Nuvilex is a biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live-cell encapsulation technology, called Cell-in-a-Box(TM). This unique technology will be used as a platform upon which treatments for several types of cancer, including advanced, inoperable pancreatic cancer, and diabetes are being built. The Company’s treatment for pancreatic cancer involves the use of the widely used anticancer prodrug, ifosfamide, together with encapsulated live cells that convert ifosfamide into its active or “cancer-killing” form. Nuvilex’s subsidiary, Medical Marijuana Sciences, Inc., is dedicated to the development of cancer treatments based upon …
Logo for Medbox, Inc.
Medbox, Inc.
Los Angeles, California
Medbox, Inc. is a publicly traded company that manufactures Medicine Dispensing Systems AKA Prescription Vending Machines. These machines are designed to automate the experience of purchasing cannabis from a dispensary and/or retail location. They were granted patents for their technology in both the United States and Canada. Headquartered in West Hills, CA, Medbox has grossed $8 million dollars since it began doing business in 2010, and has opened office locations in Los Angeles, New York, Connecticut, Arizona, Toronto, London, & Tokyo.

DISCLAIMER: The professionals and companies described are not associated or affiliated with Medical Jane, and they may not endorse Medical Jane or the information provided. The names of other companies, products and services are the property of their respective owners.

  • Subscribe

    Thank you for subscribing!
    There was a problem subscribing, please try again later.

    Sign-up to receive the latest medical cannabis research, news, and special offers straight to your inbox.

    By subscribing I agree to the Privacy Policy

    Want more exposure?

    Feature your company or event in the directory and get noticed.

    Learn more